In this study, subjects whose serum levels of ALT were higher than these suggested upper limits (i.e., the subjects in the highest tertiles) had significantly higher odds ratios of 4.9 and 6.1 for metabolic syndrome prevalence compared with those in the lowest tertiles in men and women, respectively; therefore, these suggested upper limits may be acceptable. The gene discussed is GPT; the disease is metabolic syndrome.